According to the data in Figure 7B and 7C, TRAIL plus bestatin treatment clearly enhanced the decrease in tumor volume and tumor weight, as compared with the control or single agent therapy results (**P < 0.01; ##P < 0.01). This evidence concerns the gene TNFSF10 and neoplasm.